Navigation Links
PCMA: New Legislation Would Increase Prescription Drug Costs, Limit Access
Date:5/7/2010

Independent Drugstore Lobby Seeks to Limit Fraud Detection Efforts (Again)

Washington, D.C. (Vocus) May 7, 2010 -- The Pharmaceutical Care Management Association (PCMA) released the following statement today on H.R. 5234, the PBM Audit Reform and Transparency Act of 2010, legislation championed by the independent drugstore lobby:

"Pharmacy benefit managers (PBMs) have pioneered tools – including incentivizing the use of generic medications, e-prescribing, and mail-service pharmacies – that improve savings, access, and safety for consumers and payers. Since the key to access is affordability, payers and policymakers alike should explore broader use of PBMs' cost-savings tools and reject approaches that make prescription drugs more expensive.

"The widespread use of proven PBM tools in Medicare Part D has contributed to the program's total expenditures being 43 percent lower than originally projected.

"Unfortunately, the independent drugstore lobby continues to push an agenda that increases prescription drug costs for consumers and payers and limits efforts to root out fraud, waste, and abuse. Given the increased focus on controlling health care costs, we can't afford to let anyone, including the independent pharmacy lobby, thwart congressional efforts to fight pharmacy fraud.”

In letters sent to Senate Finance Committee Ranking Member Charles Grassley (R-Iowa) and Health and Human Services (HHS) Secretary Kathleen Sebelius, PCMA outlined several proposals being pushed by the independent pharmacy lobby that could make it more difficult to root out fraud, waste, and abuse, including:

 
  • Mandating that PBMs contract with pharmacies that are currently banned from participating in federal programs.
  • Opposing the Office of Inspector General's ability to prosecute pharmacists charged with a felony.
  • Undermining the President's proposal to enhance Medicaid fraud enforcement.
  • Requiring a lengthy waiting period to remove a pharmacy from a network even with irrefutable evidence of fraud.
  • Creating unnecessary hurdles that hinder the ability of plans to audit pharmacies thoroughly.
  • Exempting independent pharmacies from routine accreditation requirements to sell Durable Medical Equipment (DME).

PCMA represents the nation's pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 210-plus million Americans.

Follow PCMA on Twitter

Contact:
Charles Coté
202-207-3605
www.pcmanet.org

# # #

Read the full story at http://www.prweb.com/releases/PCMA/pharmacy-benefit-managers/prweb3976964.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. PCMA: Federal Enrollees Don't Want Congress to Reduce Pharmacy Choices, Impose Price Controls in FEHBP
2. PCMA: Proposed Overhaul of FEHBP Pharmacy Benefit Would Undermine Cost-Saving Tools, Reduce Choices for 8 Million Americans
3. Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation
4. Duty of Care - New Driving Legislation Could Put You in Court! UKContractHireandLeasing spread the word on these new regulations
5. Age Management Medicine Conference Reports 21% Spike in Physician Registration, Linked To Frustrations With New Health Reform Legislation
6. Hospital admissions dropped after anti-smoking legislation in place
7. Minority Businesses Support Health Care Reform Legislation, According to Survey
8. Bishops Encourage Vigilance that Health Care Legislation Protects Conscience, Does Not Fund Abortion
9. MHPA Statement on Health Reform Legislation
10. The Arc Applauds House Passage of Health Care Reform Legislation
11. Statement of Ralph B. Everett, President and CEO, Joint Center for Political and Economic Studies, on House Passage of Health Reform Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PCMA: New Legislation Would Increase Prescription Drug Costs, Limit Access 
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a hot ... suggests that Americans prefer their dogs straight off the grill. Of the 90 percent ... favorite way to cook a hot dog, far outpacing other cooking methods such as ...
(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... ... MadgeTech will be showcasing its line of data logging products , ... MadgeTech headquarters. With products sold in more than 100 countries around the world, MadgeTech ... , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech data loggers around ...
(Date:5/26/2016)... ... May 26, 2016 , ... Memorial Day Weekend marks the ... Insurance is sharing tips to make sure your family and vehicle are ready ... Safety Council, there may be 439 deaths and an additional 50,500 serious injuries from ...
(Date:5/26/2016)... Rafael, CA (PRWEB) , ... May 26, 2016 ... ... will be offering campers a multitude of activities from daily practices, arts & ... self-confidence. , Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 MedDay, a biotechnology ... that an oral presentation entitled "High doses of biotin in ... will be given by Professor Ayman Tourbah , Principal ... of the European Academy of Neurology (EAN) in ... disorders 3" will take place on Sunday, 29 May 2016 ...
(Date:5/24/2016)... 24, 2016   ... primären Endpunkte und demonstriert Ebenbürtigkeit bei ... ‚ausgezeichneter plus guter , ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) ... positive Daten von der MORA-Studie der Phase III ...
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
Breaking Medicine Technology: